Evidence map›Paper›PMID 32038042›Full record

ArticleActa crystallographica. Section D, Structural biology2020

Probing the role of the conserved residue Glu166 in a class A β-lactamase using neutron and X-ray protein crystallography.

Patricia S Langan, Brendan Sullivan, Kevin L Weiss, Leighton Coates

Open access · greenAbstract read
In one paragraph

Article in Acta crystallographica. Section D, Structural biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 65% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Patricia S LanganNeutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA.
Brendan SullivanNeutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA.ORCID 0000-0001-5271-8821
Kevin L WeissNeutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA.ORCID 0000-0002-6486-8007
Leighton CoatesNeutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA.ORCID 0000-0003-2342-049X
Oak Ridge National Laboratory · US

Funding

Computational Tools for Neutron Protein CrystallographyR01GM071939 · NIGMS · UT-BATTELLE, LLC-OAK RIDGE NATIONAL LAB · PI COATES, LEIGHTON · 2004 to 2019
$4.3M
NIGMS NIH HHS R01 GM071939NIH HHS R01-GM071939
6 · The paper itself

Abstract

The amino-acid sequence of the Toho-1 β-lactamase contains several conserved residues in the active site, including Ser70, Lys73, Ser130 and Glu166, some of which coordinate a catalytic water molecule. This catalytic water molecule is essential in the acylation and deacylation parts of the reaction mechanism through which Toho-1 inactivates specific antibiotics and provides resistance to its expressing bacterial strains. To investigate the function of Glu166 in the acylation part of the catalytic mechanism, neutron and X-ray crystallographic studies were performed on a Glu166Gln mutant. The structure of this class A β-lactamase mutant provides several insights into its previously reported reduced drug-binding kinetic rates. A joint refinement of both X-ray and neutron diffraction data was used to study the effects of the Glu166Gln mutation on the active site of Toho-1. This structure reveals that while the Glu166Gln mutation has a somewhat limited impact on the positions of the conserved amino acids within the active site, it displaces the catalytic water molecule from the active site. These subtle changes offer a structural explanation for the previously observed decreases in the binding of non-β-lactam inhibitors such as the recently developed diazobicyclooctane inhibitor avibactam.

Indexed as

Glutamic AcidAmino Acid SequenceAmino Acid SubstitutionAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesBinding SitesCatalysisCatalytic DomainCrystallography, X-RayMutant ProteinsNeutron DiffractionWaterAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesGlutamic AcidMutant ProteinsWaterantibioticsneutron diffractionToho-1X-ray diffractionβ-lactamases

Identifiers

PMID32038042
PMCPMC7008513
OpenAlexW3001430459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.